| scholarly article | Q13442814 |
| P2093 | author name string | Robert D Sperduto | |
| Traci E Clemons | |||
| Natalie Kurinij | |||
| AREDS Research Group | |||
| P2860 | cites work | A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 |
| Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc | Q28206868 | ||
| Do age-related macular degeneration and cardiovascular disease share common antecedents? | Q33695980 | ||
| Vision impairment predicts five-year mortality. | Q34162924 | ||
| The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. | Q34655539 | ||
| The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. | Q36076822 | ||
| Mortality and cataract: findings from a population-based longitudinal study | Q36669210 | ||
| Cataract patients in a defined Swedish population 1986-90: VII Inpatient and outpatient standardised mortality ratios | Q36791148 | ||
| Scientific basis for medical therapy of cataracts by antioxidants | Q37620914 | ||
| Age-related eye disease and survival. The Beaver Dam Eye Study | Q40611217 | ||
| Prospective study of cataract extraction and risk of coronary heart disease in women | Q40711126 | ||
| Increased mortality rates after cataract surgery. A statistical analysis | Q41410584 | ||
| The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. | Q43796210 | ||
| Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group | Q44137448 | ||
| Association of ocular disease and mortality in a diabetic population | Q44186257 | ||
| Increased mortality among elderly patients undergoing cataract extraction | Q44844202 | ||
| National five-year mortality after inpatient cataract extraction | Q45266028 | ||
| Association between depressive symptoms and mortality in older women. Study of Osteoporotic Fractures Research Group | Q46437801 | ||
| Visual impairment, age-related cataract, and mortality. | Q50504193 | ||
| Cataract and survival in an elderly nondiabetic population. | Q51054923 | ||
| Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. | Q54136201 | ||
| Lens opacity and mortality in diabetes | Q68430672 | ||
| Relation of ocular and systemic factors to survival in diabetes | Q69946894 | ||
| Systemic hypertension and age-related maculopathy in the Framingham Study | Q70011828 | ||
| Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study | Q71933360 | ||
| Mixed lens opacities and subsequent mortality | Q73559514 | ||
| Lens opacities and mortality : the Barbados Eye Studies | Q73585625 | ||
| Baseline cataract type and 10-year mortality in the Italian-American Case-Control Study of age-related cataract | Q74461380 | ||
| Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network | Q77370491 | ||
| Visual acuity impairment and mortality in US adults | Q78502655 | ||
| Lens changes and survival in a population-based study | Q93637307 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 716-726 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 | |
| P478 | volume | 122 |
| Q46502335 | A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration |
| Q39110941 | Age-Related Macular Degeneration and Mortality: A Systematic Review and Meta-Analysis. |
| Q34450909 | Age-related cataract, cataract surgery and subsequent mortality: a systematic review and meta-analysis |
| Q35857038 | Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis |
| Q28386582 | Age-related macular degeneration and mortality in community-dwelling elders: the age, gene/environment susceptibility Reykjavik study |
| Q35629702 | Age-related macular degeneration and mortality in older women: the study of osteoporotic fractures |
| Q38618655 | Age-related macular degeneration and mortality: the Melbourne Collaborative Cohort Study. |
| Q57232723 | Age-related macular degeneration and progression of coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis |
| Q28660578 | Age-related macular degeneration and the incidence of cardiovascular disease: a systematic review and meta-analysis |
| Q90027335 | Aging With Vision Loss: A Framework for Assessing the Impact of Visual Impairment on Older Adults |
| Q24201127 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q24242944 | Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases |
| Q24202824 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration |
| Q24246241 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration |
| Q38653249 | Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. |
| Q34032328 | Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary |
| Q85649966 | Are organically grown foods safer and more healthful than conventionally grown foods? |
| Q24628833 | Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative |
| Q39742085 | Association between systemic arterial stiffness and age-related macular degeneration |
| Q90664144 | Association of Age-Related Macular Degeneration With Risk of All-Cause and Specific-Cause Mortality in the National Health and Nutrition Examination Survey, 2005 to 2008 |
| Q90538771 | Association of Age-related Macular Degeneration With Mortality in Patients With Acquired Immunodeficiency Syndrome; Role of Systemic Inflammation |
| Q48553385 | Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13. |
| Q48266197 | Association of disease-specific causes of visual impairment and 10-year mortality amongst Indigenous Australians: the Central Australian Ocular Health Study |
| Q83014743 | Bariatric surgery and the assessment of copper and zinc nutriture |
| Q39706392 | Blindness, cataract surgery and mortality in Ethiopia |
| Q80488313 | Cataract and mortality. The Beijing eye study |
| Q35054977 | Cataract, visual impairment and long-term mortality in a rural cohort in India: the Andhra Pradesh Eye Disease Study |
| Q55271693 | Changes in corneal thickness and corneal endothelial cell density after phacoemulsification cataract surgery: a double-blind randomized trial. |
| Q40197767 | Correction of interleukin-2 gene expression by in vitro zinc addition to mononuclear cells from zinc-deficient human subjects: a specific test for zinc deficiency in humans |
| Q33938168 | Dietary carbohydrate in relation to cortical and nuclear lens opacities in the melbourne visual impairment project |
| Q38529695 | Dietary modification and supplementation for the treatment of age-related macular degeneration |
| Q34333033 | Discovery of human zinc deficiency: its impact on human health and disease |
| Q40048046 | Early Age-related Macular Degeneration with Cardiovascular and Renal Comorbidities: An Analysis of the National Health and Nutrition Examination Survey, 2005-2008. |
| Q36391339 | Effect of the Y402H variant in the complement factor H gene on the incidence and progression of age-related macular degeneration: results from multistate models applied to the Beaver Dam Eye Study |
| Q30303045 | Electronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility loci. |
| Q30239897 | Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors |
| Q36951793 | Epidemiology of cataract: accomplishments over 25 years and future directions |
| Q34135654 | Factors that influence the receipt of eye care |
| Q93647478 | From the Library |
| Q42642024 | Glaucoma and mortality in the Beijing Eye Study |
| Q57176321 | Gout and the risk of age-related macular degeneration in the elderly |
| Q87769845 | IHD from copper deficiency: a unified theory |
| Q36262459 | Impact of Visual Impairment and Eye diseases on Mortality: the Singapore Malay Eye Study (SiMES). |
| Q37691145 | Impact of the discovery of human zinc deficiency on health |
| Q36834417 | Implementation of evidence-based practice in optometry |
| Q37446572 | Interactions between zinc deficiency and environmental enteropathy in developing countries. |
| Q38192127 | Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment |
| Q34666874 | Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. |
| Q79693570 | Low serum zinc concentrations predict mortality in patients referred to coronary angiography |
| Q33789053 | Low zinc status: a new risk factor for pneumonia in the elderly? |
| Q92588999 | Molecular Mechanisms of Zinc as a Pro-Antioxidant Mediator: Clinical Therapeutic Implications |
| Q90408640 | Mortality and causes of death in a population with blindness in Korea: A longitudinal follow-up study using a national sample cohort |
| Q92640807 | Mortality during 6 years of follow-up in relation to visual impairment and eye disease: results from a population-based cohort study of people aged 50 years and above in Nakuru, Kenya |
| Q42374470 | Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration |
| Q35805481 | Non-standard vision measures predict mortality in elders: the Smith-Kettlewell Institute (SKI) study |
| Q89728286 | Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus |
| Q40176460 | Ocular diseases and 10-year mortality: the Beijing Eye Study 2001/2011. |
| Q30239095 | Relation between Age-Related Macular Degeneration and Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis. |
| Q30854374 | Retinal haemodynamics in patients with age-related macular degeneration |
| Q35802797 | Risk factors for cortical, nuclear, posterior subcapsular, and mixed lens opacities: the Los Angeles Latino Eye Study |
| Q24554181 | Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19 |
| Q36571584 | Serum zinc and pneumonia in nursing home elderly |
| Q34449581 | Smoking and age-related macular degeneration: a review of association. |
| Q34522738 | Summary results and recommendations from the age-related eye disease study |
| Q89454097 | Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes |
| Q38790610 | Ten-year all-cause mortality and its association with vision among Indigenous Australians within Central Australia: the Central Australian Ocular Health Study. |
| Q28485409 | The LEGSKO mouse: a mouse model of age-related nuclear cataract based on genetic suppression of lens glutathione synthesis |
| Q35194580 | The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy |
| Q34574753 | The eye in hypertension |
| Q35593582 | The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study |
| Q37223032 | Transcutaneous electrical retinal stimulation therapy for age-related macular degeneration |
| Q57415983 | Visual Acuity and Mortality in Older People and Factors on the Pathway |
| Q33649141 | Vitamin E and all-cause mortality: a meta-analysis |
| Q39538297 | ZIP2 and ZIP4 mediate age-related zinc fluxes across the retinal pigment epithelium |
| Q33849338 | Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent |
| Q34098734 | Zinc in cancer prevention |
| Q24648059 | Zinc in human health: effect of zinc on immune cells |
| Q35600141 | Zinc is an Antioxidant and Anti-Inflammatory Agent: Its Role in Human Health |
| Q34734112 | Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis |
| Q50484718 | Zinc uptake and storage: the role of fundus pigmentation. |
| Q36795251 | Zinc: dietary intake and impact of supplementation on immune function in elderly. |
| Q79765696 | [Epidemiology of age-related macular degeneration. Situation in Spain] |
Search more.